Alemtuzumab: effective monotherapy for simultaneous B-cell chronic lymphocytic leukaemia and Sezary syndrome

被引：12
|
作者：
Gibbs, SDJ
Herbert, KE
McCormack, C
Seymour, JF
Prince, HM
机构：
[1] Peter MacCallum Canc Inst, Dept Haematol, Haematol Serv, Melbourne, Vic 8006, Australia
[2] St Vincents Hosp, Dept Dermatol, Melbourne, Vic, Australia
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2004年 / 73卷 / 06期
关键词：
alemtuzumab; chronic lymphocytic leukaemia; Sezary syndrome; pancytopenia;
D O I：
10.1111/j.1600-0609.2004.00332.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The simultaneous presentation of chronic lymphocytic leukaemia (CLL) and cutaneous T-cell lymphoma (CTCL) is a very rare occurrence where optimal treatment is unknown. We present the case of a 65-yr-old man who was successfully treated with alemtuzumab monotherapy for both disorders, but at a cost of severe infectious morbidity and prolonged pancytopenia.
引用
收藏
页码：447 / 449
页数：3
相关论文
共 50 条
  • [21] Microsatellite instability in patients with chronic B-cell lymphocytic leukaemia
    Niv, E
    Bomstein, Y
    Yuklea, M
    Lishner, M
    BRITISH JOURNAL OF CANCER, 2005, 92 (08) : 1517 - 1523
  • [22] Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia
    MainouFowler, T
    Prentice, AG
    LEUKEMIA & LYMPHOMA, 1996, 21 (5-6) : 369 - 377
  • [23] Alemtuzumab for patients with chronic lymphocytic leukaemia
    Skoetz, Nicole
    Bauer, Kathrin
    Elter, Thomas
    Monsef, Ina
    Roloff, Verena
    Hallek, Michael
    Engert, Andreas
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (02):
  • [24] Successful treatment of leukaemia cutis with cladribine in a patient with B-cell chronic lymphocytic leukaemia
    Robak, E
    Robak, T
    Biernat, W
    Bartkowiak, J
    Krykowski, E
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (04) : 775 - 780
  • [25] Abnormal T-cell function in B-cell chronic lymphocytic leukaemia
    Scrivener, S
    Goddard, RV
    Kaminski, ER
    Prentice, AG
    LEUKEMIA & LYMPHOMA, 2003, 44 (03) : 383 - 389
  • [26] Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
    Montillo, Marco
    Ricci, Francesca
    Miqueleiz, Sara
    Tedeschi, Alessandra
    Morra, Enrica
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 41 - 52
  • [27] P73 status in B-cell chronic lymphocytic leukaemia
    Leupin, N
    Lüthi, A
    Novak, U
    Grob, TJ
    Hügli, B
    Graber, H
    Fey, MF
    Tobler, A
    LEUKEMIA & LYMPHOMA, 2004, 45 (06) : 1205 - 1207
  • [28] Postzoster cutaneous pseudolymphoma in a patient with B-cell chronic lymphocytic leukaemia
    Moreira, E.
    Lisboa, C.
    Azevedo, F.
    Principe, F.
    Lima, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 (08) : 1112 - 1114
  • [29] Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia
    Haiat, Stephanie
    Billard, Christian
    Quiney, Claire
    Ajchenbaum-Cymbalista, Florence
    Kolb, Jean-Pierre
    IMMUNOLOGY, 2006, 118 (03) : 281 - 292
  • [30] B-CELL RECEPTOR SIGNALLING ENHANCES GLYCOLYSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA
    Argos, B. Valle
    Linley, A.
    Krysov, S.
    Steele, A. J.
    Forconi, F.
    Stevenson, F.
    Packham, G.
    HAEMATOLOGICA, 2014, 99 : 46 - 46
12345